MYLAN 3404 MYLAN 3404 Pill - blue capsule/oblong
Pill with imprint MYLAN 3404 MYLAN 3404 is Blue, Capsule/Oblong and has been identified as Tolterodine Tartrate Extended-Release 4 mg. It is supplied by Mylan Pharmaceuticals Inc.
Tolterodine is used in the treatment of Urinary Incontinence; Urinary Frequency; Overactive Bladder and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Tolterodine 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 3404 MYLAN 3404
Tolterodine Tartrate Extended-Release
- Imprint
- MYLAN 3404 MYLAN 3404
- Strength
- 4 mg
- Color
- Blue
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
ethylcellulose,
FD&C Blue No. 2,
gelatin,
hypromelloses,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide,
ferric oxide yellow,
ferrosoferric oxide,
potassium hydroxide,
propylene glycol,
shellac,
sucrose,
corn starch
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-3404 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 51079-0198 (Discontinued) | UDL Laboratories Inc. |
More about tolterodine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (75)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: urinary antispasmodics
- Breastfeeding
- En español
Patient resources
- Tolterodine drug information
- Tolterodine (Advanced Reading)
- Tolterodine Tablets
- Tolterodine Extended-Release Capsules
Other brands
Professional resources
- Tolterodine monograph
- Tolterodine Tartrate Capsules (FDA)
- Tolterodine Tartrate ER Tablets (FDA)
- Tolterodine Tartrate Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
